We are live on !
Find out more
Cheviot Value Management Portfolio holdings
AUM
$1.03B
Turnover
20.7%
1-Year Est. Return
18.09%
This Fund
S&P 500
This Quarter Est. Return
+5.27%
1 Year Est. Return
+18.09%
3 Year Est. Return
+86.95%
5 Year Est. Return
+110.6%
10 Year Est. Return
+309.9%
AUM
$193M
AUM Growth
+$9.09M
(+4.9%)
Cap. Flow
+$813K
Cap. Flow % of AUM
Cap. Flow %
0.42%
Top 10 Holdings %
Top 10 Hldgs %
61.27%
Holding
60
New
6
Increased
24
Reduced
24
Closed
–
Avg Time Held
2.5
years
Top 10 Avg Time Held
2.5
years
Top 20 Avg Time Held
3.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GG
Goldcorp Inc
GG
|
+$408K |
| 2 |
GE Aerospace
GE
|
+$331K |
| 3 |
Agnico Eagle Mines
AEM
|
+$320K |
| 4 |
Omnicom Group
OMC
|
+$302K |
| 5 |
BAYER AG SPONS ADR
BAY
|
+$297K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$476K |
| 2 |
Microsoft
MSFT
|
+$444K |
| 3 |
VanEck Gold Miners ETF
GDX
|
+$441K |
| 4 |
American International
AIG
|
+$288K |
| 5 |
Becton Dickinson
BDX
|
+$193K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.6% |
| 2 | Financials | 26.03% |
| 3 | Materials | 10.4% |
| 4 | Technology | 10.38% |
| 5 | Miscellaneous | 10.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Berkshire Hathaway Class B
BRK.B
$1.26T
| $37.8M | 19.59% |
190,818
-415
| -0.2% | -$78.8K |
2013 Q2
18 quarters
|
|
2
Johnson & Johnson
JNJ
$688B
| $14.4M | 7.45% |
102,928
-958
| -0.9% | -$133K |
2013 Q2
18 quarters
|
|
3
Sprott Physical Gold and Silver Trust
CEF
$6.46B
| $12.6M | 6.52% |
939,550
+13,123
| +1% | +$173K |
2013 Q2
18 quarters
|
|
|
4
Microsoft
MSFT
$3.89T
| $12.2M | 6.34% |
143,005
-5,410
| -4% | -$444K |
2013 Q2
18 quarters
|
|
5
Pfizer
PFE
$165B
| $8.38M | 4.34% |
243,878
+974
| +0.4% | +$33.2K |
2013 Q2
18 quarters
|
|
6
Newmont
NEM
$118B
| $7.73M | 4% |
206,037
-1,680
| -0.8% | -$61.8K |
2013 Q2
18 quarters
|
|
7
Apple
AAPL
$5.18T
| $6.94M | 3.6% |
164,088
+284
| +0.2% | +$11.9K |
2014 Q1
15 quarters
|
|
|
8
Agnico Eagle Mines
AEM
$90.2B
| $6.42M | 3.33% |
139,023
+7,169
| +5% | +$320K |
2013 Q2
18 quarters
|
|
|
9
DELISTED
BAYER AG SPONS ADR
BAY
| $6.38M | 3.3% |
205,101
+9,567
| +5% | +$297K |
2016 Q4
4 quarters
|
|
|
10
AbbVie
ABBV
$521B
| $5.4M | 2.8% |
55,818
-5,054
| -8% | -$476K |
2013 Q2
18 quarters
|
|
11
Medtronic
MDT
$132B
| $5.27M | 2.73% |
65,249
-1,303
| -2% | -$104K |
2013 Q2
18 quarters
|
|
12
McDonald's
MCD
$192B
| $4.72M | 2.44% |
27,406
-764
| -3% | -$128K |
2013 Q4
16 quarters
|
|
13
Markel Group
MKL
$24.2B
| $4.6M | 2.38% |
4,035
-28
| -0.7% | -$30.6K |
2013 Q2
18 quarters
|
|
14
Chevron
CVX
$429B
| $4.34M | 2.25% |
34,660
-407
| -1% | -$48.3K |
2013 Q2
18 quarters
|
|
|
15
Becton Dickinson
BDX
$59.4B
| $3.97M | 2.05% |
18,990
-921
| -5% | -$193K |
2013 Q2
18 quarters
|
|
16
Pan American Silver
PAAS
$15.5B
| $3.85M | 1.99% |
247,001
+478
| +0.2% | +$7.57K |
2013 Q2
18 quarters
|
|
|
17
VanEck Gold Miners ETF
GDX
$25.3B
| $3.6M | 1.86% |
154,923
-19,360
| -11% | -$441K |
2013 Q2
18 quarters
|
|
18
Abbott
ABT
$188B
| $3.44M | 1.78% |
60,332
-459
| -0.8% | -$25.4K |
2013 Q2
18 quarters
|
|
|
19
American International
AIG
$43B
| $3.38M | 1.75% |
56,709
-4,689
| -8% | -$288K |
2013 Q2
18 quarters
|
|
20
Merck
MRK
$364B
| $2.96M | 1.54% |
55,208
-1,749
| -3% | -$97K |
2013 Q2
18 quarters
|
|
|
FFH
21
DELISTED
FAIRFAX FINL HLDGS LTD SUB VTG
FFH
| $2.94M | 1.52% |
5,517
+96
| +2% | +$51.1K |
2013 Q2
18 quarters
|
|
22
PepsiCo
PEP
$198B
| $2.74M | 1.42% |
22,891
+210
| +0.9% | +$24K |
2015 Q1
11 quarters
|
|
23
CVS Health
CVS
$114B
| $2.56M | 1.33% |
35,306
-1,652
| -4% | -$120K |
2013 Q2
18 quarters
|
|
|
24
GE Aerospace
GE
$344B
| $2.51M | 1.3% |
30,046
+3,467
| +13% | +$331K |
2016 Q4
4 quarters
|
|
25
ExxonMobil
XOM
$696B
| $2.1M | 1.09% |
25,165
+162
| +0.6% | +$13.4K |
2015 Q3
9 quarters
|
|
Similar funds
Cheviot Value Management's Q4 2017 Portfolio in Review
As of Q4 2017, Cheviot Value Management held 60 positions worth $193M, up 4.9% from $184M the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Cheviot Value Management's Q4 2017 filing shows 6 new, 24 increased and 24 reduced positions. Its largest new stake was Omnicom Group: 4,214 shares worth $307K. The largest sale was AbbVie, an estimated $476K.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 29% a quarter earlier, followed by Financials and Materials.
- Cheviot Value Management's largest Q4 2017 buy was Omnicom Group: 4,214 shares worth $307K.
- Cheviot Value Management added most to Goldcorp Inc in Q4 2017, an estimated $408K increase.
- Cheviot Value Management's biggest Q4 2017 reduction was AbbVie, cutting an estimated $476K.
- Cheviot Value Management's ten largest holdings make up 61% of its $193M portfolio in Q4 2017.
- Cheviot Value Management opened 6 new positions and closed 0 in Q4 2017.
- Cheviot Value Management's portfolio value rose 4.9% quarter-over-quarter to $193M.
Based on Cheviot Value Management's 13F filing for Q4 2017, filed 13 Feb 2018.